Study types
- other 3
- article 1
- rct 1
Condition tags
- endometriosis 4
- adenomyosis 1
Top journals
Frequent coauthors
- M. Steven Piver 3
- K Ohkawa 2
- K Takada 2
- Y Terashima 2
- K Mitani 1
- K Yamada 1
- L Blumenson 1
- E Kimura 1
- M Murae 1
- N Takizawa 1
Murine monoclonal antibody CF511, raised against human ovarian clear cell carcinoma, detects a glycoprotein (Mr 600 kDa) called CF511 antigen which is elevated in the serum of many patients with ovarian carcinoma. A competitive enzyme-linke…
From January 1981 to December 1988, a prospective trial was conducted on 216 consecutive patients undergoing hysterectomy for FIGO stage I endometrial adenocarcinoma to determine the accuracy of intraoperative frozen section (IFS) diagnosis…
The murine monoclonal antibody (Mab) against human common epithelial ovarian carcinoma, CF511, was generated by immunising mice with human fetal tissue extract from early first trimester, followed by booster injection of an ovarian cancer c…
From 1958 to 1967, a prospective randomized trial was conducted in 189 women with stage I, group I endometrial adenocarcinoma, comparing treatment by hysterectomy alone, preoperative uterine radium followed by hysterectomy, and hysterectomy…